In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CeNeRx BioPharma Inc.

Latest From CeNeRx BioPharma Inc.

PPD appoints three new therapeutic area heads

CeNeRx Completes Series C To Fund Trial; Find Partner

The biopharma raises a third round of financing to help finish a mid-stage trial for its antidepressant TriRima.

BioPharmaceutical Strategy

Top Partnering Opportunities In Neuroscience: The Ugly Truth

Consultant notes some promising candidates in a challenging space for investment.

BioPharmaceutical Deals

Recent Financings of Private Companies (10/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CeNeRx BioPharma Inc.
  • Senior Management
  • Barry Brand, CEO
    Dan Burch, MD, EVP, R&D & CMO
  • Contact Info
  • CeNeRx BioPharma Inc.
    Phone: (919) 234-4072
    270 Cornerstone Dr.
    Ste. 103
    Cary, NC 27519